RxDoctor Payments Data

Sofya Kleyn

Geriatric Medicine · New York, NYNPI 1972628865

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.4% of the total across 69 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 22.7% — the pattern of someone who eats at a lot of different presentations.

$1,762in general payments, 2019–2025

Across 69 payments — averaging $25.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Viiv Healthcare Company$401
  • AbbVie$255
  • Amgen$242
  • Lilly USA, LLC$167
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$119
  • Abbott$104
  • plus $474 from 12 others

What the payments were for

  • Food & beverage$1,73398%
  • Education$292%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,762 in reported general payments places this provider in the 85th percentile of 400 geriatric medicine providers in New York.

See all geriatric medicine providers in New York

Medicare billing

Part B allowed, 2024
$77,576
Medicare patients
149
Services billed
819

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Sucralfate16$2,208
Diclofenac Sodium11$1,238
Ciprofloxacin Hcl23$233
Levothyroxine Sodium19$211
Losartan Potassium22$182
Metoprolol Succinate18$176
Fluticasone Propionate12$101
Hydralazine Hcl14$91
Atorvastatin Calcium21$86
Lisinopril11$80
Furosemide14$66
Atenolol16$48
Amlodipine Besylate14$44

Paid to pharmacies, not to this prescriber.

Other geriatric medicine in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →